Alsaid et al. (2017) used contrast enhanced MRI to study the impact of a mAb AccretaMab (anti HER3) on its HER3 positive tumor growth inhibitory effects in human xenograft tumor‐bearing mice. Here, ERBB3 is linked to neoplasm.